Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. - Diamant, Michaela; Van Gaal, Luc; Stranks, Stephen; Northrup, Justin; Dachuang Cao; Taylor, Kristin; Trautmann, Michael (Lancet, 2010)